Top Markets
#1 MarsCoin MarsCoin +55.22%
#2 Palladium Network Palladium Network +52.93%
#3 Siren Siren +27.72%
#4 Useless Coin Useless Coin +25.64%
#5 Status Status +20.53%
#6 edgeX edgeX +18.18%
#7 Bedrock Bedrock +17.35%
#8 PondCoin PondCoin +15.89%
#9 Asteroid Shiba Asteroid Shiba +15.47%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
Coin of the day
MarsCoin MarsCoin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Sinphar Pharmaceutical Co. Ltd. Sinphar Pharmaceutical Co. Ltd.

Sinphar Pharmaceutical Co. Ltd.

1734
Classifica tra le azioni #18491
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the... Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.
Prezzo delle azioni
$0.97305026
Capitalizzazione di mercato
$196.18M
Variazione (1 giorno)
-0.16%
Variazione (1 anno)
0.50%
Paese
TW
Scambia Sinphar Pharmaceutical Co. Ltd. (1734)

Categoria

Healthcare
Rapporto P/S per Sinphar Pharmaceutical Co. Ltd. (1734)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sinphar Pharmaceutical Co. Ltd., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Sinphar Pharmaceutical Co. Ltd. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.73 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.40 -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT